1919–1930 encephalitis lethargica epidemic
Overview of the encephalitis lethargica epidemic from 1919 to 1930
The 1919–1930 encephalitis lethargica epidemic was a global outbreak of a mysterious neurological disease known as encephalitis lethargica. This epidemic affected millions of people worldwide, causing a range of symptoms from mild lethargy to severe neurological impairment and death.
Overview
Encephalitis lethargica, also known as "sleepy sickness," is characterized by high fever, headache, double vision, delayed physical and mental response, and lethargy. In severe cases, patients may enter a coma-like state. The disease primarily affects the central nervous system, leading to encephalitis, or inflammation of the brain.
History
The epidemic began in 1919, shortly after the end of World War I, and continued until 1930. During this period, the disease spread rapidly across Europe, North America, and other parts of the world. The cause of the epidemic remains unknown, although it is believed to be viral in origin.
Symptoms and Clinical Presentation
Patients with encephalitis lethargica presented with a wide range of symptoms. Early signs included fever, sore throat, and headache, followed by neurological symptoms such as lethargy, sleep disturbances, and movement disorders. Some patients developed parkinsonism, a condition characterized by tremors, rigidity, and bradykinesia.
Pathophysiology
The exact pathophysiology of encephalitis lethargica is not well understood. It is hypothesized that the disease may be caused by an autoimmune response triggered by a viral infection. The basal ganglia and midbrain are often affected, leading to the characteristic movement disorders and behavioral changes.
Impact and Legacy
The epidemic had a profound impact on public health and neurology. Many patients who survived the acute phase of the illness were left with chronic neurological deficits, including post-encephalitic parkinsonism. The epidemic also spurred significant research into the causes and treatment of viral encephalitis and movement disorders.
Research and Discoveries
The Austrian neurologist Constantin von Economo was one of the first to describe the disease in detail. His work laid the foundation for further research into the condition. Despite extensive study, the precise cause of encephalitis lethargica remains elusive, and no definitive treatment has been found.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD